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A B S T R A C T
Comprehensive interventions including components of stigma and discrimination reduction in schizophrenia in
low- and middle-income countries (LMICs) are lacking. We developed a community-based comprehensive in-
tervention to evaluate its eﬀects on clinical symptoms, social functioning, internalized stigma and discrimination
among patients with schizophrenia. A randomized controlled trial including an intervention group (n=169)
and a control group (n= 158) was performed. The intervention group received comprehensive intervention
(strategies against stigma and discrimination, psycho-education, social skills training and cognitive behavioral
therapy) and the control group received face to face interview. Both lasted for nine months. Participants were
measured at baseline, 6 months and 9 months using the Internalized Stigma of Mental Illness scale (ISMI),
Discrimination and Stigma Scale (DISC-12), Global Assessment of Functioning (GAF), Schizophrenia Quality of
Life Scale (SQLS), Self-Esteem Scale (SES), Brief Psychiatric Rating Scale (BPRS) and PANSS negative scale
(PANSS-N). Insight and medication compliance were evaluated by senior psychiatrists. Data were analyzed by
descriptive statistics, t-test, chi-square test or Fisher’s exact test. Linear Mixed Models were used to show in-
tervention eﬀectiveness on scales. General Linear Mixed Models with multinomial logistic link function were
used to assess the eﬀectiveness on medication compliance and insight. We found a signiﬁcant reduction on
anticipated discrimination, BPRS and PANSS-N total scores, and an elevation on overcoming stigma and GAF in
the intervention group after 9 months. These suggested the intervention may be eﬀective in reducing anticipated
discrimination, increasing skills overcoming stigma as well as improving clinical symptoms and social func-
tioning in Chinese patients with schizophrenia.
1. Introduction
Schizophrenia is a complex mental illness (Jablensky, 2000; Prince
et al., 2007) aﬀecting millions of people (Bloomﬁeld et al., 2016) and
also is one of the conditions associated with the highest economic
burden of health care in the world (Howes and Murray, 2014). Though
numerous studies have demonstrated the eﬀectiveness of anti-psychotic
medications in controlling positive symptoms (Patel et al., 2007), it is
diﬃcult for medication treatments to remit negative symptoms and
cognitive impairment eﬀectively, which are correlated with social
functioning. Therefore treatment with medication alone is insuﬃcient
to promote the rehabilitation of patients with schizophrenia. Treat-
ments for this population should combine medication with psychosocial
interventions (Asher et al., 2017). Nowadays, it is recommended a
balanced care model between hospital and community, which can
provide better mental health services. However, there are several
challenges occurred during the delivery of community mental health
services, stigma and discrimination have been proved to be an im-
portant risk factor in community mental health (Thornicroft et al.,
2016a). It is well known that people with schizophrenia often
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experience high levels of stigma and discrimination (Harangozo et al.,
2014; Rose et al., 2011; Thornicroft et al., 2009), which often lead to
negative consequences, such as poor access to mental and physical
health care (Corrigan et al., 2014), low self-esteem, social withdrawal,
help-seeking of mental health obstacles (Brohan et al., 2011; Schomerus
and Angermeyer, 2008), high rates of unemployment, poverty, suicide
and homelessness (Dereje et al., 2012; Link and Phelan, 2006), low
literacy and premature death (Thornicroft et al., 2016b). These aspects
of stigmatisation are sometimes described by people with schizophrenia
as worse than the primary condition.
Programs breaking down stigma and discrimination have been
running for several years in Western high-income countries (HICs)
(Corker et al., 2016; Henderson and Thornicroft et al., 2009; Knaak and
Patten, 2016; Stuart, 2008; Thornicroft et al., 2014), to assert that
people with mental disorders should be treated without stigmatization
and discrimination (Saxena et al., 2013). Research evidence suggests
that approaches aiming to improve mental health related knowledge
and modify the negative attitudes and behaviors could eﬀectively re-
duce stigma (Link, 2001; Pinfold et al., 2003; Thornicroft et al., 2007).
However, most of the previous studies are from HICs (Thornicroft et al.,
2016b) and studies in low-and middle-income countries (LMICs) re-
main few. It is necessary to integrate strategies against stigma and
discrimination into the community mental health services. Hence, a
comprehensive intervention aiming at decreasing clinical symptoms,
improving social functioning and reducing stigma and discrimination is
desired for patients with schizophrenia who living in community.
Psycho-education is an important approach to educate people with
mental health knowledge and erase the misconceptions about mental
illness. In China, one of the groups of LMICs, there is a rich literature on
the eﬀectiveness of psycho-education in improving general psycho-
pathology and social functioning among people with schizophrenia and
their families and relatives (Chien and Thompson, 2014; Ran et al.,
2003; Xiang et al., 1994; Xiong et al., 1994; Zhang and Yan, 1993).
Cognitive behavioral therapy (CBT) and social skills training (SST) have
also been proved to be indispensable ingredients in comprehensive
interventions. CBT focuses on reframing psychotic ideas and rebuilding
healthy beliefs in the mind of people with schizophrenia (Sarin and
Wallin, 2013; Wykes et al., 2008). SST could increase the skills solving
problems, improve communication abilities and enhance self-manage-
ment capabilities (Kang et al., 2016).
A new community model for mental health named SASD (strategies
against stigma and discrimination) is supplied by the ﬁrst author who is
expert in community psychiatry and cultural psychiatry. The goals of
SASD are to rebuild self-conﬁdence, improve self-esteem, learn self-
acceptance and increase skills combating stigma and discrimination. To
our knowledge, this should be the ﬁrst study to carry out such a com-
prehensive intervention in community in Guangzhou, China. Our hy-
pothesis is that after the comprehensive intervention, we would see a
reduction on stigma and discrimination, as well as an improvement on
social functioning and clinical symptoms in patients with schizo-
phrenia.
2. Methods
2.1. Study design and participants
Guangzhou is the capital city of Guangdong province, comprising
nearly 8 million registered people with an adjusted lifetime prevalence
rate of mental disorders of about 15.8% (Zhao et al., 2009). More than
20,000 of 50,000 people who have been registered in the system of
Guangzhou severe mental disorders management database were diag-
nosed as having schizophrenia. The current study was conducted at
Guangzhou Huiai Hospital. We used a stratiﬁed cluster random sam-
pling in this study. According to the geographical locations, the 12
administrative regions in Guangzhou City were divided into 2 clusters
(6 central districts and 6 suburban districts). Then we randomly
selected two central districts (Tianhe and Liwan) and two suburban
districts (Huadu and Nansha) from the 2 clusters (Li et al., 2017). Fi-
nally, we randomly divided the four districts into two groups: the
control group (Liwan and Huadu) and the intervention group (Tianhe
and Nansha), so each group contained a central district and a suburban
district. The sample size was calculated by the formula in our previous
published paper (Li et al., 2015a), assuming a 10% drop-out rate and a
signiﬁcance level of 5% (two sided) and a power of 80%, then 120
participants from each district were randomly recruited.
Participants were included if they: (1) were diagnosed as having
schizophrenia according to ICD-10; (2) were aged between 18 and 50
years old; (3) ﬁnished primary school education; (4) took anti-psychotic
medications with clinical stability; and (5) lived in the local community
during the study. Participants were excluded if they: (1) had substance
abuse, acute risk of suicide and violence; (2) were unable to understand
and ﬁll out the scales and questionnaires; (3) comorbid other serious
physical disease, such as cerebrovascular diseases; and (4) were preg-
nant and / or lactating.
A total of 199 participants were enrolled in the intervention group
(109 in Tianhe and 90 in Nansha) and a total of 185 participants were
enrolled in the control group (100 in Liwan and 85 in Huadu) at
baseline. Most participants were excluded because of the deterioration,
being lost to interview (e.g. moving) or refusing to continue the inter-
vention. The details were shown in Fig. 1. Written informed consent
was obtained from the participants after the procedure had been fully
explained.
Participants in the control group were provided with the face to face
interview, which was delivered by the community psychiatrists or
general practitioners. The main details contained the assessments of
mental state, especially the psychopathological symptoms; daily life;
situation of taking medications; and social activities. Participants in the
intervention group received the comprehensive intervention, which
was delivered by two experienced psychiatrists, one psychotherapist
and a social worker.
The main intervention contents included SASD, psycho-education,
SST and CBT. Table 1 could diﬀerentiate the elements of the inter-
vention, and show how the intervention modalities combined. Both
groups received anti-psychotics as usual and operated for an equal
amount of time (nine months). Because of the human resource limita-
tions, the intervention was delivered eight times in total: monthly in the
ﬁrst six months and twice in the last three months. Twenty-four mod-
ules were included in the comprehensive intervention, and completed
in eight phases. Three modules (every modality with one module) were
given during every phase for 120min. Participants attending every
phase of this intervention were recorded and some intervention sites
were also taken photos when the participants agreed to do these.
There was a manual for the comprehensive intervention, which was
formulated according to the manual of WHO Mental Health Gap Action
Program (mhGAP), and a series of relative books, such as Mental Health
Gap Action Program Intervention Guide (WHO, 2010), Schizophrenia
Guideline in China (Shu, 2007), Social Training for Schizophrenia-a-
step-by-step Guide (Bellack et al., 2004), Schizophrenia Rehabilitation
Instruction Manual in China (Wong, 2009), CBT Skills Workbook:
Practical Exercises and Worksheets to Promote Change (Gregory, 2010)
and Understanding the Stigma of Mental Illness: Theory and Interven-
tions (Julio and Norman, 2008). The manual also considered a series of
practices coping with stigma and discrimination around the world
(Corrigan and Watson, 2002; Lasalvia et al., 2013; Link et al., 2004).
PowerPoint slides were fabricated during the process.
2.2. Interventions
2.2.1. Strategies against stigma and discrimination (SASD)
The main contents were approximately as follows: Introduction
about the background of stigma, consequences of stigma, strategies
against stigma and related practice training. All these were aimed at
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helping patients to accept this illness and taking a positive attitude to
cope with the residual symptoms; rebuilding their self-conﬁdence,
strengthening their legal knowledge, educating patients that they had
the rights in education, matrimony, employment, etc; helping patients
to improve self-esteem to believe that they could make contribution to
the society; practicing patients with the social skills and learning skills
to build relationship with others. All these strategies were contributed
to helping patients increase social interaction. This step was executed
by an experienced psychiatrist, who had experienced the training.
2.2.2. Psycho-education
The psycho-education for patients with schizophrenia consisted of
seven modules: Introduction about the concepts of schizophrenia;
Medication treatment of schizophrenia; Side-eﬀects of antipsychotic
drugs; Phase review; Rehabilitation of schizophrenia; Preferential
policy on schizophrenia in Guangzhou; Review Module. This step was
executed by an experienced psychiatrist who had been trained in the
intervention procedure.
2.2.3. Social skills training (SST)
SST in this study included six modules: Rehabilitation of self-man-
agement, learning to live a healthy life; Social communication skills,
learning to manage emotion; Vocational skills, learning to show good
mental outlook in an interview; Medication self-management skills,
learning to understand schizophrenia and its medication treatment and
also the side eﬀects; Self-monitoring, learning to assess the treatment,
seeking for the useful methods to deal with the persistent symptoms;
Reintegration to society skills, encouraging participants to join the so-
cial activities, to cultivate the communication skills and build a har-
monious atmosphere in the community. This step was executed by the
social worker and the psychiatrists who had experienced the unity
training.
2.2.4. Cognitive behavioral therapy (CBT)
CBT was conducted mainly as three steps. First, built a conﬁdential
relationship with participants by listening carefully to them; second,
educated patients the knowledge of CBT theories, such as ABC theory of
emotion, automatic thinking and positive thinking building, mean-
while, helped the participants to learn cognitive and behavioral coping
skills; third, focused on skills to solve problems, discussed the ad-
vantages and disadvantages of medication, and learned methods to
identify and cope with the warning signs. Homework was assigned after
each module to help patients consolidate what they had learned during
the therapy. Trainers had to do a review before a new module to ensure
Fig. 1. CONSORT (Consolidated Standards of Reporting Trials) diagram.
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that patients had mastered the skills learned in previous modules. This
step was carried out by the psychiatrists and the psychotherapist who
had experienced the unity training.
2.3. Measurements
2.3.1. Internalized stigma of mental illness scale (ISMI)
We used the Chinese version of ISMI, which has good validity and
reliability to assess participants’ experience of internalized stigma. This
is a self-administered scale including 29 items and uses a Likert scale
from 1= strongly disagree to 4= strongly agree. A higher ISMI score
represents higher internalized stigma (Li et al., 2009).
2.3.2. Discrimination and stigma scale (DISC-12)
We used the Chinese version of DISC-12, which has good validity
and test-retest reliability to assess participants' experiences of stigma
and discrimination on work, relationships, parenting, housing, social
organizations, leisure, and religious activities during the past 12
months. The scale consists of four subscales (Brohan et al., 2013): ex-
perienced discrimination, which including 21 items, a higher score
indicates greater experienced discrimination; anticipated discrimina-
tion, which including 4 items, a higher score indicates greater limita-
tion in their daily life; overcoming stigma, which including 2 items, a
higher score indicates knowing more strategies to overcome dis-
crimination; positive treatment, which including 5 items, a higher po-
sitive treatment score indicates more positive treatment being reported.
For further information about this Chinese version of DISC-12 see Li
et al (2016).
2.3.3. Global assessment of functioning (GAF)
We used the Chinese version of GAF, which has good validity and
the reliability to assess psychological, social and occupational func-
tioning in schizophrenia. This is an interview-administered ques-
tionnaire with a single-item rating from 0 to 100. A higher score re-
presents better psychological, social and occupational functioning
(Zhang, 1984).
2.3.4. Schizophrenia quality of life scale (SQLS)
We used the Chinese version of SQLS, which has good validity and
reliability to assess participants’ quality of life. This is a self-adminis-
tered scale including 30 items. All items are scored on a 5-point Likert
scale (0= never, 1= rarely, 2= sometimes, 3= often, and 4= al-
ways) except four items are reverse-coded. A lower score represents a
better quality of life, while a higher score indicates a poorer quality of
life (Li et al., 2003).
2.3.5. Self-Esteem scale (SES)
We used the Chinese version of SES, which has good validity and
reliability to indicate the degree of participants’ agreement or dis-
agreement with statements about their self-esteem and self-deprecation.
This is a self-administered scale. A higher score indicates a lower self-
esteem (Wang et al., 1998).
2.3.6. Brief psychiatric rating scale (BPRS)
We used the Chinese version of BPRS, which has been frequently
used and has good validity and reliability to assess the severity and
change of psychotic symptoms in patients with schizophrenia. This is an
interview-administered scale with 18 items. A higher total score re-
presents more severe psychotic symptoms experienced by the partici-
pants (Zhang et al., 1983).
2.3.7. Positive and negative syndrome scale for schizophrenia (PANSS)
We used the Chinese version of PANSS negative scale (PANSS-N),
which has been frequently used and has good validity and reliability to
assess the severity and change of negative symptoms in patients with
schizophrenia. This study only used the negative syndrome subscale.
The main reason was that PANSS-N was associated with the social
function, and PANSS-N could increase the sensitivity to analysis nega-
tive symptoms. Another reason was the time needed and burden for
participants to complete all scales. This is an interview-administered
scale with 7 items relating to negative symptoms. A higher total score
represents more serious negative symptoms. (Si et al., 2004).
2.3.8. Insight and medication compliance assessment
Insight and medication compliance were assessed by senior psy-
chiatrists. Both insight and medication compliance assessment were
ranked from one to three. The severity of insight was rated as 1 (no
insight), 2 (part insight) and 3 (complete insight). The severity of
medication compliance rated as 1 (complete medication compliance), 2
(part medication compliance) and 3 (extremely no medication
compliance).The proportion of every grade was calculated to assess the
situation of insight and medication compliance in patients with schi-
zophrenia.
2.4. Procedure
The trial was conducted from April 2015 to April 2016. The study
protocol was approved by Research Ethics Committee of Guangzhou
Huiai Hospital (Number 012, 2015). This study was registered as a
Randomized Controlled Trial, number ChiCTR-IPR-15006246. The in-
terviewers (two experienced psychiatrists, one psychotherapist and a
social worker) received one day of intensive training on how to do the
implementation of this intervention. The raters (three experienced
psychiatrists, one psychotherapist and one psychological consultant)
were also trained in another day to ensure the inter-rater reliability
during the whole assessment. Both interviewers and raters were trained
by the research conductor (the ﬁrst author) who was experienced in
Table 1
The contents of the comprehensive intervention.
Modalities Modules and contents
Psycho-education/SASD 1.Introduction of the background on
schizophrenia
2.Medical treatment of schizophrenia
3.Side-eﬀects of antipsychotic drugs
4.A review of the three modules before
5.Rehabilitation of schizophrenia
6.Preherential policy on schizophrenia in
Guangzhou, China
7.Introduction of stigma in schizophrenia
8.A review of the modules given before
SST/SASD 9.Rehabilitation of self-management
10.Social communication skills
11.Vocational skills training
12.Medication self-management skills
13.Self-monitoring
14.Reintegration to society skills
15.Consequences of stigma and discrimination
16.Skills against stigma and discrimination
CBT/SASD 17.Build a conﬁdential relationship with patients
18.Introduction of CBT Ⅰ: ABC theory of emotion
19.Introduction of CBT Ⅱ: Automatic thinking
20. Introduction of CBT Ⅲ: Build a positive
thinking
21.Correct the misunderstandings of
schizophrenia
22. Anti-stigma skills training
23.Self-acceptance learning
24.A review of the modules given before
Notes: Abbreviations: SASD= strategies against stigma and discrimination,
SST= social skills training, CBT= cognitive behavioral therapy,
ABC=Antecedent, Belief, Consequence. Twenty-four modules were included
in the comprehensive intervention, and completed in eight phases. Three
modules (every modality with one module) were given during every phase for
120min.
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illustrating the PowerPoint slides and conducting these scales and
questionnaires. They were also supervised by the research conductor
during the whole trial. All modules were conducted at the participants’
local community health service center.
2.5. Data collection
Data were collected at 3 points: 1) baseline: pre-intervention; 2) 6
months: mid-intervention; and 3) 9 months: end-intervention. BPRS,
PANSS-N, GAF, insight and medication compliance were completed by
three experienced psychiatrists via face to face interview. DISC-12 was
completed by one psychotherapist and one psychological consultant via
reading the items to the participants and participants showed them the
answers. ISMI, SQLS and SES were completed by the participants
themselves.
2.6. Statistical analysis
All statistical analyses were performed using IBM SPSS Statistics
20.0 (IBM Corporation, USA). Descriptive statistics, including the mean,
standard deviation (SD), frequency, and proportion were used to de-
scribe the demographics and the outcomes of study participants at
baseline, 6 months and 9 months (the primary endpoint). Diﬀerences
between the participants’ demographics by interventions were assessed
by the t-test for continuous variables or the chi-square test or Fisher’s
exact test for categorical variables.
The analyses of outcomes were based on the intention to treat
principle. Linear Mixed Models were used to show intervention eﬀec-
tiveness on BPRS, PANSS-N, GAF, SQLS, SES, ISMI, DISC-12 subscales.
General Linear Mixed Models with multinomial logistic link function
were used to assess the eﬀectiveness on medication compliance and
insight. Regression coeﬃcients (b) or odds ratio (OR) with 95% con-
ﬁdence intervals (CI), and intra-class correlation (ICC) resulting from
clusters (districts) were calculated. Participants’ demographics were not
adjusted because there were no signiﬁcant diﬀerences between inter-
vention and control groups. All statistical tests were two-tailed with a
signiﬁcance level of 0.05.
3. Results
3.1. Recruitment and sample characteristics
A total of 199 participants were recruited to the intervention group
and 185 to the control group at baseline. At 6 months, 169 participants
(85%) in the intervention group and 158 participants (85%) in the
control group completed the intervention. At 9 months, 169 partici-
pants (85%) in the intervention group and 154 participants (83%) in
the control group completed the intervention. The results of the chi-
square test revealed that there was no signiﬁcant diﬀerence between
the two groups at the three time points (p=0.985). Non-participation
was mainly the results of deterioration, lost or refusal (see CONSORT
chart at Fig. 1). The ﬁnal analyses of outcomes were based on the in-
tention to treat principle.
Tables 2 and 3 showed the demographic and clinical characteristics
of the intervention group and control group at baseline. There were no
signiﬁcant diﬀerences in age, gender, years of education, race, marital
status, occupations, number of hospitalizations and duration of illness.
However, participants in the intervention group had signiﬁcantly lower
scores in BPRS and PANSS-N scales than those in the control group at
baseline (p<0.05), apart from the two variables, the two groups were
well matched and there were no signiﬁcant diﬀerences identiﬁed in
other baseline clinical characteristics (p>0.05).
3.2. Outcomes at 6 months and 9 months
Participants’ psychological and clinical changes were measured at 6
months and 9 months with the following scales: ISMI, DISC-12, GAF,
SQLS, SES, BPRS and PANSS-N. Baseline diﬀerences in BPRS and
PANSS-N scores were controlled when examining any of the outcomes.
Table 3 showed the changes of the two groups at the two time points.
3.2.1. Changes in stigma and discrimination
As shown in Table 3, there was no statistically signiﬁcant reduction
on ISMI total scores in the intervention group when compared with the
control group after 9 months intervention (p=0.440). However, some
primary outcomes in DISC-12 subscales were noteworthy. We noted a
signiﬁcant elevation in the subscale of overcoming stigma in the in-
tervention group when compared with the control group after the in-
tervention and there was a signiﬁcant interaction between intervention
and time (95% CI 0.18–0.67, p=0.001). At 6 months and 9 months,
mean scores of overcoming stigma in intervention group were sig-
niﬁcantly higher than the control group (both p < 0.001). What’s
more, the anticipated discrimination score in the intervention group
was signiﬁcantly lower than the control group after 9 months inter-
vention and there was a signiﬁcant interaction between intervention
and time (95% CI −0.59 to −0.01, p=0.046).
There was no signiﬁcant diﬀerence by the end of the intervention on
experienced discrimination in the intervention group when compared
with the control group after 9 months intervention (p > 0.05). At 9
months, though the t-test result showed there was a signiﬁcant decrease
on positive treatment in the intervention group when compared with
the control group (p=0.04), Linear mixed model showed that there
was no signiﬁcant diﬀerence by the end of the intervention on positive
treatment comparing the two groups (p > 0.05). Details were shown in
Figs. 2 and 3 and Table 3.
3.2.2. Changes in functioning and quality of life
As shown in Table 3 and Fig. 4, GAF total score in intervention
group was signiﬁcantly higher than the control group after the inter-
vention and there was a signiﬁcant interaction between intervention
and time (95%CI 6.88–11.46, p<0.001). At 6 months and 9 months,
GAF total scores in intervention group were signiﬁcantly higher than
the control group (both p<0.001). There were no signiﬁcant diﬀer-
ences on SQLS between the two groups after 9 months intervention
(p>0.05).
Table 2
Socio-demographic characteristics (baseline).
Characteristics Intervention
Group (n= 199)
Control
Group
(n= 185)
t-value/
x2-value
p-value
Age, years: mean (SD) 40.21 (7.57) 39.70 (7.83) 0.65 0.52
Education, years: mean
(SD)
10.31 (2.51) 9.92 (2.69) 1.46 0.15
Race (Han) n(%) 198 (99.5) 182 (98.4) 0.36
Sex n(%) 0.70 0.40
Male 98 (49.2) 99 (53.5)
Female 101 (50.8) 86 (46.5)
Marital status n(%) 3.31 0.35
Single 103 (51.8) 95 (51.4)
Married 76 (38.2) 70 (37.8)
Divorce/Widowed 20 (10.1) 20 (10.8)
Occupation n(%) 2.46 0.12
Yes 65 (32.7) 47 (25.4)
No 134 (67.3) 138 (74.6)
Duration of illness, years:
mean (SD)
14.11 (7.49) 15.00 (8.45) −1.09 0.28
Number of
hospitalizations,
times: mean (SD)
2.60 (2.50) 2.36 (3.51) 0.76 0.45
Notes: Data were indicated by mean, standard deviation (SD), frequency and
proportion.
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3.2.3. Changes in psychotic symptoms
As shown in Table 3 and Fig. 5, we noted that BPRS total score in
the intervention group was signiﬁcantly lower than the control group
after the intervention and there was a signiﬁcant interaction between
intervention and time (95%CI -4.92 to -2.67, p<0.001). At 6 months
and 9 months, there was a signiﬁcant reduction on BPRS total score in
the intervention group when compared with the control group (both
p<0.05), after adjustment for baseline BPRS total scores. At the same
time, we noted that PANSS-N total score in intervention group was
signiﬁcantly lower than the control group at the end of the intervention
and there was a signiﬁcant interaction between intervention and time
(95%CI -4.31 to -2.67, p<0.001) (Table 3 and Fig. 6), after adjustment
for baseline PANSS-N total scores. At 6 months and 9 months, there was
a signiﬁcant reduction on PANSS-N total score in the intervention group
when compared with the control group (both p<0.05).
3.2.4. Changes in insight and medication compliance
In addition, we measured participants’ medication compliance and
insight. We found there were no signiﬁcantly diﬀerences on insight and
medication compliance between the two groups at the end of the in-
tervention (both p>0.05). Details were shown in Table 3.
Table 3
Eﬀectiveness of the comprehensive interventions at baseline, 6-month and 9-month.
Intervention Intervention Group (n= 169) Control Group (n=158) b(95%CI)/OR(95%CI) p-value ICC
Baseline 6-month 9-month Baseline 6-month 9-month
BPRS total score: mean (SD)# 26.60 (6.39) 22.75 (4.19) 21.92 (3.44) 28.12 (7.84) 24.65 (5.77) 25.65 (6.72) −3.79(−4.92 to
−2.67)
<0.001 0.2511
PANSS-N total score : mean
(SD)#
16.40 (5.28) 10.73 (3.42) 9.71 (3.06) 17.96 (5.43) 12.14 (4.23) 13.06 (4.53) −3.49(−4.31 to
−2.67)
<0.001 0.1248
GAF total score : mean (SD)# 63.76 (10.59) 73.46 (10.19) 77.98 (8.91) 61.61 (12.27) 67.22 (11.88) 67.70
(10.62)
9.17(6.88 to11.46) <0.001 0.2280
SQLS total score : mean (SD) 31.64 (15.74) 29.61 (13.54) 30.60 (14.10) 31.95 (15.97) 31.71 (16.90) 31.24
(16.00)
−0.06(−3.53 to 0.65) 0.973 0.1989
ISMI total score : mean (SD) 2.30 (0.38) 2.21 (0.40) 2.24 (0.37) 2.30 (0.40) 2.28 (0.39) 2.30 (0.39) −0.04(−0.14 to0.06) 0.440 0.1235
DISC-12 subscales: mean (SD)
Experienced discrimination 0.20 (0.26) 0.18 (0.23) 0.16 (0.23) 0.21 (0.29) 0.22 (0.31) 0.21 (0.29) −0.05(−0.12 to 0.03) 0.205 0.2520
Anticipated discrimination# 0.79 (0.72) 0.51 (0.65) 0.52 (0.68) 0.79 (0.72) 0.62 (0.68) 0.84 (0.86) −0.30(−0.59 to
−0.01)
0.046 0.2898
Overcoming stigma# 0.73 (0.67) 1.16 (0.83) 1.09 (0.83) 0.78 (0.71) 0.72 (0.64) 0.63 (0.62) 0.43(0.18 to 0.67) 0.001 0.3578
Positive treatment# 0.75 (0.66) 0.65 (0.62) 0.50 (0.45) 0.70 (0.60) 0.53 (0.56) 0.61 (0.48) −0.11(−0.30 to 0.07) 0.220 0.2298
SES total score : mean (SD) 22.95 (3.92) 22.51 (3.68) 22.89 (3.61) 23.34 (3.88) 23.56 (3.88) 23.23 (3.77) −0.14(−1.25 to 0.97) 0.805 0.2168
Medication compliance n (%) 0.33(0.10 to 1.15) 0.082 0.4152
Complete compliance 155(77.9) 160(94.7) 163(95.9) 137(74.1) 138(87.3) 138(89)
Part compliance 42(21.1) 8(4.7) 7(4.1) 46(24.9) 17(10.8) 13(8.4)
No compliance 2(1.0) 1(0.6) 0(0.0) 2(1.0) 3(1.9) 4(2.6)
Insight n (%) 1.39(0.90 to 2.15) 0.134 0.4723
Complete insight 22(11.1) 80(47.3) 92(54.1) 24(13.0) 60(38.0) 70(45.2)
Part insight 134(67.3) 85(50.30) 75(44.1) 104(56.2) 91(57.6) 74(47.7)
No insight 43(21.6) 4(2.40) 3(1.8) 57(30.8) 7(4.4) 11(7.1)
Notes: The analyses of outcomes were based on the intention to treat principle. Data were indicated by mean, standard deviation (SD), frequency and proportion.
Abbreviations: ICC=intra-class correlation, ICC is the proportion of variance in the outcome that can be accounted for by diﬀerences among districts. BPRS=Brief
Psychiatric Rating Scale. PANSS-N=PANSS negative scale. GAF=Global Assessment of Functioning. SQLS= Schizophrenia Quality of Life Scale.
ISMI= Internalized Stigma of Mental Illness scale. SES=Self-Esteem Scale. DISC=Discrimination and Stigma Scale. #: the interaction between intervention and
time was signiﬁcant (p<0.05).
Fig. 2. DISC Overcoming stigma scores of the intervention group and control
group by time point. Data were indicated by mean (standard error).
***p < 0.001. Fig. 3. DISC Anticipated discrimination Scores of the intervention group and
control group by time point. Data were indicated by mean (standard error).
***p < 0.001.
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3.2.5. Changes in self-esteem
What’s more, the outcome of SES showed that there was no sig-
niﬁcant diﬀerence between the two groups at the end of the interven-
tion (p=0.805). At 6 months, SES total score in intervention group was
signiﬁcantly lower than the control group (p=0.01). Details were
shown in Table 3.
4. Discussion
To our knowledge, interventions related with stigma among people
with mental illness are still in their infancy in China (Xu et al., 2017).
This is the ﬁrst study to conduct a comprehensive intervention among
patients with schizophrenia who living in community in Guangzhou,
China and to assess its eﬀects on clinical symptoms, social functioning,
internalized stigma and discrimination. Few eﬀective programs have
integrated with strategies against stigma and discrimination in the
Chinese community mental health services. Generally speaking, the
ﬁndings in this study indicate that the comprehensive intervention may
be eﬀective for people with schizophrenia, especially on discrimination
reduction, clinical symptoms lessening and social functioning im-
provement.
The results of this study suggested that internalized stigma in pa-
tients with schizophrenia has not been reduced after this intervention
program. This is similar to the study of Chatterjee et al (2014), who also
found no additional contribution in reducing stigma after a community-
based intervention (Chatterjee et al., 2014). Stigma is a complicate
psycho-social issue, which can be emerged when amounts of compo-
nents interact. Self-stigma occurs when an individual with mental ill-
ness internalizes the negative stereotypes, adopts prejudice and loses
self-esteem and self-eﬃcacy. It is an internalized and consolidated
performance of negative thoughts and experience, which is pervasive
and diﬃcult to eradicate. Interventions from one level or one facet
could not change it eﬀectively. Patients’ attitudes and behaviors to-
wards the illness can be inﬂuenced by the family members and the
public, which can hinder or increase diﬃculties for patients to ﬁght
with the internalized stigma. Hence, these may indicate that interven-
tions towards the family members and the public to correct the mis-
understandings of mental disorders and rebuild a positive thinking are
necessary. Though there were no signiﬁcant diﬀerences found between
the two groups, we could see the reduced trend appeared in the inter-
vention group, we assume that the eﬀect of interventions against in-
ternalized stigma could be signiﬁcantly improved when combing with
strategies combating public stigma.
We found some positive results in relation to discrimination, which
may have some positive eﬀects on erasing discrimination and stigma in
the future. This study showed that the skills of overcoming stigma in the
intervention group were signiﬁcantly improved at both 6 months and 9
months, and there was a signiﬁcant interaction between intervention
and time, this suggested that the comprehensive intervention could
educate participants to be familiar with more skills to reduce dis-
crimination. The anticipated discrimination in the intervention group
was signiﬁcantly lower after the comprehensive intervention, in-
dicating that fewer participants stopped themselves from starting re-
lationships and they would not avoid or shun others who knew they had
mental illness.
These results are consistent with the ﬁndings of Shin and Lukens
(2002), who found greater coping skills in Korean Americans with a
diagnosis of schizophrenia (Shin and Lukens, 2002). The reasons can be
explained from the contents of the comprehensive methods. There are
eight modules in the intervention related with stigma and discrimina-
tion, which means SASD is educated to the patients during most of the
interventional period, which therefore can ensure patients to contact
with these strategies in most of their time. SASD aims at rebuilding
patients’ conﬁdence by encouraging them to communicate with others
and training patients with skills to face with stigma and deal with some
related problems. The eﬀects of other three methods should not be ig-
nored. At the same time the stigma reduction intervention was not di-
rectly based upon the principle of interpersonal contact, and so the
results indicate that such interpersonal contact can be usefully em-
ployed in future intervention studies intended to reduce stigma
(Thornicroft et al., 2016b)
Fig. 4. GAF Scores of the intervention group and control group by time point.
Data were indicated by mean (standard error). GAF=Global Assessment of
Functioning. ***p < 0.001.
Fig. 5. BPRS Scores of the intervention group and control group by time point.
Data were indicated by mean (standard error). BPRS=Brief Psychiatric Rating
Scale. *p < 0.05, **p < 0.01, ***p < 0.001.
Fig. 6. PANSS-N Scores of the intervention group and control group by time
point. Data were indicated by mean (standard error). PANSS-N=PANSS nega-
tive scale. **p < 0.01, ***p < 0.001.
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Psycho-education could give participants a greater understanding
and knowledge of schizophrenia (Armijo et al., 2013). SST could im-
prove their social functioning and interpersonal relations and give them
hope (Yildiz et al., 2004). The format of CBT could attract patients to
attend the program, reduce social withdraw and the regular contact
with psychiatrists could consolidate the attitude and behavior change
(Kersten et al., 2016). All these may contribute to reducing dis-
crimination. Linear mixed models showed that there were no signiﬁcant
changes on the subscales of experienced discrimination or positive
treatment. These indicated this intervention might not play a role on
the two parameters, or its eﬀects were inﬂuenced by the external-en-
vironment.
Lastly, this study indicated a signiﬁcant improvement in social
functioning, which was assessed by GAF. GAF score in the intervention
group was greatly increased at both 6 months and 9 months, and there
was a signiﬁcant interaction between intervention and time. Our results
were consistent with Temple and Ho (2005), who found an improve-
ment of global psychosocial functioning in patients with schizophrenia
(Temple and Ho, 2005). Pena et al (2016) also stated a similar result of
social function in patients with schizophrenia who participated in the
integrative cognitive remediation program (Pena et al., 2016). Some
possible reasons may be that participants in this study not only received
professional psycho-education but practiced social skills training. What
is more, a large number of researchers have proved that the format and
speciﬁc strategies of CBT can improve global and social functioning (Li
et al., 2015b; Sarin and Wallin, 2013; Wykes et al., 2005).
Another interesting ﬁnding was the signiﬁcant improvement of self-
esteem at 6 months and an increased trend at 9 months though with no
signiﬁcant diﬀerences. This indicates that the intervention improves
self-esteem to some extent, and may be because of the reduced fre-
quency in the last three months that we do not get the expected results
in 9 months. So a higher frequency and intensity of interventions are
needed in future research. Furthermore, we noted a signiﬁcant reduc-
tion of BPRS and PANSS-N scores in the intervention group after 9
months intervention, which were consistent with previous studies
(Fujita et al., 2010; Shin and Lukens, 2002; Tempier et al., 2012). These
ﬁndings reﬂect the comprehensive intervention can reduce psychotic
symptoms, especially some negative symptoms in patients with schi-
zophrenia. It’s worth noting that participants in the study have a
median duration of about 14 years of illness and symptoms were
moderate in severity. For this group of people with long-term and se-
vere symptoms, these improvements in BPRS and PANSS-N could be
viewed as important outcomes.
In conclusion, although our intervention has no directly signiﬁcant
eﬀects on self-stigma, it still has implications for the peers for its eﬀects
on discrimination reduction, clinical symptoms lessening, and social
functioning improvement. The frequency of the intervention can be
more intensive in order to improve self-esteem and approaches to re-
duce self-stigma are needed to be identiﬁed.
4.1. Strengths and limitations of the study
Several limitations in this study should be taken into consideration.
First, the intervention was conducted only eight times during 9 months
because of the human resource limitations. Second, all the evaluation
researches have the subjective bias, it’s also diﬃcult for this study to
eliminate this bias. Third, there may have a synergy eﬀect among the
four components of this intervention. It is diﬃcult to calculate the
contribution of each component in this study. Further explorations are
needed to examine the eﬀectiveness of each intervention component.
Fourth, this study only showed the eﬀects of the program at the mo-
ment of intervention end-point, the eﬀectiveness of the follow-up is
undergoing. Fifth, the intervention to reduce stigma was not directly
based upon the principle of inter-persona contact. Despite these lim-
itations, we believe that our study also has some clear advantages. First,
this study was under the overall guidance of the World Psychiatric
Association’s Global Anti-stigma program. Second, this is the ﬁrst study
about comprehensive intervention, which including strategies against
stigma and discrimination, conducted among people with schizo-
phrenia in the community in China. Third, the scales used in this study
have good psychometric properties in their Chinese versions.
4.2. Implications of the study
This study suggests that the comprehensive intervention package
used, (including SASD, psycho-education, SST and CBT) could have
some positive impacts in patients with schizophrenia in community in
Guangzhou, China, such as reduction on discrimination, improvement
on social functioning and the clinical symptoms, especially the negative
symptoms. However, schizophrenia may be a long-term condition, and
a longer duration of follow-up is needed to show any additional beneﬁts
of the comprehensive interventions (Ran et al., 2015). What’s more,
family intervention was included in our design originally, however, we
didn’t do it in the later study, two reasons can explain this problem.
First, because of the inconvenience of the family members, it’s hard for
us to gather them together. Second, because of the long duration of this
illness in the patients, family members may not show too much care on
them. It’s indicated the importance of interventions on family members
and the public. Additionally, the biggest challenge in this study may be
the manpower for delivery of essential mental health interventions.
“Task-shifting” is an eﬀective approach to relieve the limitations of
manpower, mental health specialists can via brief training and appro-
priate supervision of non-specialist health professionals to strengthen
human resources. In this study, participants in the control group were
cared by the community psychiatrists or general practitioners. There
was a support policy in China that general practitioners could achieve
the license of psychiatry if they passed the psychiatric training, which
could make up for the shortage of human resources in mental health.
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